Scholarlink

<p>Systemic lupus erythematosus (SLE) is a complex autoimmune disorder characterized by immune dysregulation and multi-organ involvement. This study focuses on the dysregulated expression of lncRNAs SNHG15 and OTUD6B-AS1 as potential biomarkers for disease progression and diagnostics. A comprehensive bioinformatics analysis of RNA-sequencing data from PBMCs of SLE patients and healthy controls identified differentially expressed lncRNAs, miRNAs, and mRNAs. The DAVID tool was employed for functional enrichment analyses to elucidate the biological pathways and functions associated with these differentially expressed genes. Concurrently, the STRING database was used to predict protein–protein interactions, enhancing our understanding of the molecular interactions and networks involved. Additionally, the relationships between lncRNAs, miRNAs, and mRNAs were explored through the construction of a competing endogenous RNA (ceRNA) network, visualized using Cytoscape. The findings from the bioinformatics analysis were substantiated by qPCR, which validated the differential expression of the lncRNAs SNHG15 and OTUD6B-AS1 in a larger cohort of samples, affirming their potential roles as biomarkers for SLE. The findings revealed significant up-regulation of SNHG15 (fold change = 2.01, <i>p</i> = 0.0011) and down-regulation of OTUD6B-AS1 (fold change = 0.26, <i>p</i> &lt; 0.0001) in SLE patients compared to controls. Correlation analyses linked OTUD6B-AS1 expression with hematological and inflammatory markers, while SNHG15 was associated with liver function indicators. ROC analysis demonstrated high diagnostic accuracy for both lncRNAs, particularly OTUD6B-AS1. This study establishes SNHG15 and OTUD6B-AS1 as promising biomarkers for SLE, highlighting their distinct associations with immune and organ-specific pathology. The robust diagnostic performance of OTUD6B-AS1, evidenced by its high sensitivity and specificity, suggests its utility in developing more accurate diagnostic tests for SLE. Furthermore, the correlation of these lncRNAs with disease activity markers underscores their potential role in monitoring disease progression and severity in SLE patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dysregulated Long Non-coding RNAs SNHG15 and OTUD6B-AS1 in Systemic Lupus Erythematosus: Insights from Bioinformatics Analysis and Experimental Validation

  • 期刊论文

  • 发表日期：

    2025年5月2日

查看全文
  • Ahmad Golestanifar,
  • Arezo Masroor,
  • Hengameh Khedri,
  • Shiva Zeini,
  • Azim Nejatizadeh

摘要

Systemic lupus erythematosus (SLE) is a complex autoimmune disorder characterized by immune dysregulation and multi-organ involvement. This study focuses on the dysregulated expression of lncRNAs SNHG15 and OTUD6B-AS1 as potential biomarkers for disease progression and diagnostics. A comprehensive bioinformatics analysis of RNA-sequencing data from PBMCs of SLE patients and healthy controls identified differentially expressed lncRNAs, miRNAs, and mRNAs. The DAVID tool was employed for functional enrichment analyses to elucidate the biological pathways and functions associated with these differentially expressed genes. Concurrently, the STRING database was used to predict protein–protein interactions, enhancing our understanding of the molecular interactions and networks involved. Additionally, the relationships between lncRNAs, miRNAs, and mRNAs were explored through the construction of a competing endogenous RNA (ceRNA) network, visualized using Cytoscape. The findings from the bioinformatics analysis were substantiated by qPCR, which validated the differential expression of the lncRNAs SNHG15 and OTUD6B-AS1 in a larger cohort of samples, affirming their potential roles as biomarkers for SLE. The findings revealed significant up-regulation of SNHG15 (fold change = 2.01, p = 0.0011) and down-regulation of OTUD6B-AS1 (fold change = 0.26, p < 0.0001) in SLE patients compared to controls. Correlation analyses linked OTUD6B-AS1 expression with hematological and inflammatory markers, while SNHG15 was associated with liver function indicators. ROC analysis demonstrated high diagnostic accuracy for both lncRNAs, particularly OTUD6B-AS1. This study establishes SNHG15 and OTUD6B-AS1 as promising biomarkers for SLE, highlighting their distinct associations with immune and organ-specific pathology. The robust diagnostic performance of OTUD6B-AS1, evidenced by its high sensitivity and specificity, suggests its utility in developing more accurate diagnostic tests for SLE. Furthermore, the correlation of these lncRNAs with disease activity markers underscores their potential role in monitoring disease progression and severity in SLE patients.